Targeting Interleukin-7 Signalling in Ulcerative Colitis: Rationale and Emerging Clinical Evidence. [PDF]
Manti M, Raspa V, Patel K, Honap S.
europepmc +1 more source
ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review). [PDF]
Zhang J +15 more
europepmc +1 more source
Therapeutic Potential of Isoniazid in Inflammatory Skin Diseases: A Review. [PDF]
Zhang S +5 more
europepmc +1 more source
Biological and Targeted Therapy in Non-Infectious Uveitis: Current Evidence and Future Perspectives. [PDF]
Mitkova-Hristova VT +2 more
europepmc +1 more source
Vunakizumab-induced severe ulcerative colitis during treatment of psoriatic arthritis: a case report and literature review. [PDF]
Cui Y, Tian J, Ma Z.
europepmc +1 more source
Deletion of a distal IRF4 element prevents inflammation-induced reprogramming of human regulatory T cell fate. [PDF]
Ho P +6 more
europepmc +1 more source
Inflammatory immune mechanisms underlying the comorbidity of psoriasis and atherosclerosis: clinical implications. [PDF]
Xin W, Tian Y, Wang S, Zhang S, Chen Z.
europepmc +1 more source
Targeted Therapies in Inflammatory Bowel Disease: Mechanisms, Comparative Evidence, and Clinical Translation. [PDF]
Pavel C +10 more
europepmc +1 more source
Real-World Treatment Patterns, Healthcare Resource Utilisation, and Costs in Biologic-Naïve Patients with Moderate-to-Severe Psoriasis Treated with Biologics in France. [PDF]
Passeron T +6 more
europepmc +1 more source

